Peter F. Lang
Director of Finance/CFO chez OPTHEA LIMITED
Profil
Peter F.
Lang is currently the Chief Financial Officer at Opthea Ltd.
He was previously a Managing Director & Partner at Ridge Advisory LLC and the Chief Financial Officer at Aerie Pharmaceuticals, Inc. for a brief period in 2022.
Lang holds an MBA from The University of Chicago Booth School of Business and an undergraduate degree from The Wharton School of the University of Pennsylvania.
Postes actifs de Peter F. Lang
| Sociétés | Poste | Début |
|---|---|---|
| OPTHEA LIMITED | Director of Finance/CFO | 27/10/2023 |
Anciens postes connus de Peter F. Lang
| Sociétés | Poste | Fin |
|---|---|---|
| AERIE PHARMACEUTICALS, INC. | Director of Finance/CFO | 21/11/2022 |
| Ridge Advisory LLC | Corporate Officer/Principal | - |
Formation de Peter F. Lang
| The University of Chicago Booth School of Business | Masters Business Admin |
| The Wharton School of the University of Pennsylvania | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| OPTHEA LIMITED | Health Technology |
| Entreprise privées | 2 |
|---|---|
Aerie Pharmaceuticals, Inc.
 Aerie Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aerie Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye. Its products include Rhopressa, Roclatan, AR-13503, and AR-1105. The company was founded by David L. Epstein, Casey C. Kopczynski, Thomas J. van Haarlem, and Eric J. Toone on January 1, 2005 and is headquartered in Durham, NCForth Worth, TX. | Health Technology |
| Ridge Advisory LLC |
